| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics, Inc. | Common Stock | 4.9% | $12.5M | -$323K | 9.69M | -2.51% | BB Biotech AG | Mar 4, 2025 |
| BDTX | Black Diamond Therapeutics, Inc. | Common Stock | 4.8% | $3.88M | -$8.21M | 2.73M | -67.9% | BB Biotech AG | Mar 19, 2025 |
| SAGE | Sage Therapeutics, Inc. | Common Stock | 1.9% | $8.14M | 1.18M | BB Biotech AG | Jan 13, 2025 | ||
| AGIO | Agios Pharmaceuticals, Inc. | Common Stock | 0% | $0 | -$96M | 0 | -100% | BB Biotech AG | Jun 1, 2025 |
| MGNX | MACROGENICS INC | Common Stock | 0% | $0 | -$15.3M | 0 | -100% | BB Biotech AG | Jun 1, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|